[Federal Register Volume 80, Number 236 (Wednesday, December 9, 2015)]
[Notices]
[Pages 76493-76499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30968]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 80 FR 73766-73769, dated November 25, 2015) is 
amended to reflect the reorganization of the Division of Global HIV/
AIDS, Center for Global Health, Centers for Disease Control and 
Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and the mission and function 
statements for the Division of Global HIV/AIDS (CWG) and insert the 
following:
    Division of Global HIV and TB (CWG). The Division of Global HIV and 
TB (DGHT) provides technical assistance to host governments, working 
through its strong partnerships with Ministries of Health and local and 
international partners to implement integrated HIV/AIDS clinical and 
preventive services and systems; develop and strengthen laboratory 
services; and provide epidemiologic science, informatics, and research 
support to develop sustainable public health systems in resource-
constrained countries. DGHT: (1) Provides leadership, management, and 
services to DGHT country offices; (2) implements integrated evidence-
based prevention, care, and treatment programs and services; (3) 
evaluates program costs, cost effectiveness and impact to assist with 
prioritization, inform program planning, and appropriate rates of 
program expansion, and strengthens capacity for sustainable, high 
quality research and service implementation to indigenous partners and 
Ministries of Health; (4) builds sustainable public health capacity in 
laboratory services and systems; (5) ensures epidemiologic and 
scientific excellence in HIV/AIDS programs; (6) contributes to the 
broader scientific body of knowledge in global public health by 
systematically evaluating the scope and quality of global HIV/AIDS and 
TB programs; (7) implements operations and effectiveness research to 
inform the design of current and future programs as well as optimize 
allocation of human and financial resources; (8) strengthens in-country 
capacity to design and implement HIV/AIDS surveillance systems and 
surveys; (9) builds host government public health management capacity 
and trains in-country public heath workforce with the goal of long-term 
program sustainability; (10) supports host government capacity to 
monitor and evaluate the process, outcome, and impact of HIV 
prevention, care, and treatment programs; and (11) helps countries 
respond to public health emergencies, assisting in response planning 
and implementation with Ministries of Health and other international 
partners.
    Office of the Director (CWG1). (1) Provides strategic leadership, 
guidance, management and oversight to all DGHT programs and ensures 
coordination and communication across its branches and with other CDC 
programs including CDC/Washington; U.S. Government (USG) agencies, 
including the Department of Health and Human Services (HHS), the United 
States Agency for International Development (USAID), and Department of 
State (DoS);

[[Page 76494]]

and other international organizations; (2) plans, implements, and 
oversees all field programs along with other USG agencies; (3) provides 
oversight, leadership, and strategic guidance for the management of 
DGHT country/program directors and country offices for all matters of 
daily operation, including management of global workforce staff; (4) 
provides leadership and guidance on policy development and 
interpretation, budget formulation, program planning, issues 
management, management and operations, and evaluation; (5) provides 
leadership and oversight for the development of communication materials 
and dissemination strategies to share best practices through media, 
partners, and other audiences to strengthen the public health response; 
(6) oversees identification of opportunities for leveraging and 
enhancing partnerships for public health protection and synergies with 
other Agency programs and partners; (7) oversees DGHT management and 
operations services in coordination with appropriate CDC staff offices, 
including processing travel and assisting with accountability and 
management of HHS/CDC property, facilities, and equipment; (8) oversees 
timely and sufficient DGHT staff placement through recruitment, hiring, 
and orienting of qualified staff; (9) provides leadership to ensure 
retention of qualified staff by providing workforce management and 
career development services for DGHT staff; (10) oversees supports to 
ensure scientific excellence for all DGHT scientific, programmatic, and 
informational documents/materials which includes providing scientific 
review and clearance of manuscripts for publication, abstracts for 
presentation, and protocols for institutional review boards and human 
subjects review; (11) provides leadership and support for global public 
health evaluation and operational research to maximize the 
effectiveness and quality of global HIV/AIDS interventions to guide 
DGHT programs and policies; (12) establishes and implements standards 
for organizational excellence; (13) provides direct technical 
assistance and maintains relationships with host country partners, and 
responds to other health needs as required; (14) assures accountability 
of program funds and reports on progress; and (15) collaborates with 
other CDC and HHS programs and offices; other USG agencies; and other 
national and international organizations.
    International Laboratory Branch (CWGB). (1) Serves as a reference 
laboratory that provides guidance on quality assurance, continuous 
quality improvement, certification and accreditation for international 
laboratory and point of care testing (POCT) sites; (2) provides 
technical assistance to country programs in the areas of laboratory 
information systems, laboratory systems, and linkages throughout the 
diagnostic cascade; (3) provides training packages, training, guidance, 
and support to host nations, other USG agencies and international and 
national partners on HIV, tuberculosis (TB), Sexually Transmitted 
Infection (STI), and opportunistic infection (OI) diagnostics and 
monitoring techniques; HIV incidence testing; hematology; clinical 
chemistry; CD4; TB diagnostic and treatment monitoring testing; anti-
tuberculosis drug susceptibility testing (DST) ; antiretroviral 
treatment (ART) resistance testing; dried blood spot polymerase chain 
reaction for early infant diagnosis; viral load monitoring; and 
ensuring the quality of laboratories and testing activities; (4) serves 
as a training center of excellence for HIV/TB/STI diagnostics for 
international sites; (5) provides laboratory assistance to 
international surveillance activities to monitor trends of HIV 
prevalence and incidence; (6) provides technical assistance and quality 
assurance in support of and TB prevalence and drug resistance surveys 
(6) assists in the surveillance of HIV subtypes in the overall context 
of supporting sero-surveillance programs; (7) assists in the 
surveillance and evaluation of HIV drug resistance as part of 
antiretroviral care and treatment programs; (8) serves as a reference 
laboratory for the World Health Organization (WHO)-CDC HIV drug 
resistance network and as a WHO Supranational TB Reference Laboratory 
(8) develops strategies and methodologies to meet the clinical and 
diagnostic needs of HIV/AIDS and TB programs; (9) assists in the 
evaluation and validation of serologic and nucleic acid assays for 
measurement of HIV incidence to enable evaluation of effectiveness of 
prevention programs; evaluates performance of new assays and platforms 
for HIV and TB diagnosis and treatment monitoring; (11) develops 
comprehensive testing algorithms for HIV diagnosis; (12) provides 
technical guidance on introduction of new TB diagnostic tests and 
algorithms; (13) contributes to operational research to maximize the 
effectiveness and quality of global HIV/AIDS and TB interventions to 
guide Division, Agency, and PEPFAR programs and policies; (14) conducts 
laboratory capacity assessments and assists in development of 
infrastructure for effective implementation of programs in countries 
where DGHT operates; (15) provides laboratory guidance and support on 
national strategic planning and quality management of tiered laboratory 
systems in host nations and consults on all technical aspects of 
laboratory procurement, standardization, quality control and quality 
assurance; (16) works with international accrediting organizations to 
establish guidance, training, and tools for accreditation of laboratory 
systems in resource-poor settings; (17) supports ongoing collaboration 
with international laboratory experts and national and regional 
laboratory personnel to resolve technical issues and develops 
international tools, guidelines, curriculum and other resources to 
improve laboratory capacity in host nations; (18) develops and 
implements strategies to expand the laboratory health workforce and 
increase human capacity of host government public health programs to 
strengthen and ensure sustainable, integrated public health responses 
to HIV/AIDS and TB; (19) promotes a transition toward greater 
sustainability of laboratory systems through the support of country-
driven efforts; (20) establishes strategic Public Private Partnerships 
for strengthening laboratory systems, training, development of referral 
systems for transporting samples, and quality management schemes; (19) 
ensures scientific excellence for all branch manuscripts, protocols, 
and programs in collaboration with the DGHT Office of the Director (OD) 
science office; (21) contributes to the greater body of scientific 
knowledge through the presentation of laboratory operational research 
findings at conferences and through publications in peer reviewed 
journals; and (22) collaborates with other DGHT branches; other CDC 
(e.g., DTBE, DGHP) and HHS programs and offices; other USG agencies; 
and other national and international organizations.
    HIV Prevention Branch (CWGC). (1) Provides technical assistance and 
builds capacity to implement, improve, and maximize effectiveness of 
HIV prevention programs; (2) provides technical assistance for scale-up 
of prevention interventions and linkage to HIV clinical services; (3) 
helps to develop, expand, and evaluate HIV testing and counseling 
programs in both clinical and community settings to assure that all 
persons know their HIV status; (4) assists in implementing, and 
monitoring the quality and impact of programs for linking HIV infected

[[Page 76495]]

persons to health services for HIV care and treatment; (5) helps 
strengthen, expand, and make accessible programs to access key 
populations and to link HIV infected persons to prevention, care, and 
treatment programs; (6) assists in tailoring HIV prevention programs to 
meet the special needs of youth, drug-using populations, and other key 
populations; (7) assists in safe and effective implementation of 
biomedical interventions, including the scale-up of medical male 
circumcision; (8) provides technical assistance to PEPFAR partner 
countries to assure availability of safe blood by attaining blood 
center accreditation, quality assurance for blood bank laboratories, 
and appropriate health information systems for blood services; (9) 
supports global surveillance systems for transfusion- and injection-
associated HIV transmission and the transmission of other blood-borne 
pathogens of public health importance; (10) conducts investigations and 
supports the development of surveillance systems to track medical 
injection use and misuse and provides technical assistance to countries 
to reduce demand for medical injections; (11) contributes to 
operational research to maximize the effectiveness and quality of 
global HIV/AIDS prevention interventions to guide programs and 
policies; (12) establishes strategic Public Private Partnerships to 
build capacity for and maximize effectiveness of HIV prevention 
programs in host countries; (13) ensures scientific excellence for all 
branch manuscripts, protocols, and programs in collaboration with the 
DGHT OD science office; and (14) collaborates with other DGHT branches, 
CDC and HHS programs and offices, USG agencies, and national and 
international organizations.
    HIV Care and Treatment Branch (CWGD). (1) Provides technical 
assistance and builds capacity in developing and implementing 
sustainable care and treatment programs for persons with HIV/AIDS. This 
includes diagnosis, linkage to care, and care and treatment services 
for HIV/AIDS, HIV-related tuberculosis, other opportunistic infections, 
and opportunistic cancers; (2) assists countries to achieve the 90-90-
90 goals articulated by UNAIDS and by PEPFAR 3.0; (3) provides 
technical expertise and support to country programs, partners, and 
Ministries of Health in planning, implementing, and evaluating 
effective strategies for care and treatment of persons with HIV; (4) 
provides HIV care and treatment expertise to country programs, 
partners, and Ministries of Health on management, standard operating 
procedures, human resources, physical infrastructure, training, drug 
and health commodities management, laboratory services, monitoring and 
evaluation, community services, linkage between HIV and other programs, 
promotion of prevention, and sustainability; (5) provides support for 
continuous quality improvement of HIV care and treatment programs; (6) 
promotes appropriate integration of services, including HIV prevention 
interventions into clinical care and treatment settings and HIV 
services into general medical services; (7) conducts operational 
research in collaboration with country programs to identify best 
practices, address barriers, and respond to emerging scientific issues 
related to HIV care and treatment service delivery; (8) collaborates 
with international partners to synthesize the scientific body of 
knowledge on HIV care and treatment, including TB/HIV co-infection; (9) 
collaborates with international partners to develop and disseminate 
tools (e.g., protocols and training curricula), guidelines and 
policies; (10) supports analysis of program costs and cost-
effectiveness to assist with prioritization, inform program planning, 
and determine appropriate rates of program expansion; (11) supports 
capacity building of host countries to transition responsibility for 
implementation of HIV care and treatment services to indigenous 
partners and Ministries of Health, with result of increasing ownership, 
sustainability and service delivery cost efficiencies; (12) establishes 
strategic Public Private Partnerships aimed at augmenting capacity for 
developing and implementing sustainable care and treatment programs, 
including diagnosis, linkage to care, and care and treatment services 
for HIV/AIDS, HIV-related tuberculosis, other opportunistic infections, 
and opportunistic cancers; (13) ensures scientific excellence for all 
branch Manuscripts, protocols, and programs in collaboration with the 
DGHT OD science office; and (14) collaborates with other DGHT branches; 
other CDC and HHS programs and offices; other USG agencies; and other 
national and international organizations.
    Maternal and Child Health Branch (CWGE). (1) Supports the 
international scale-up of comprehensive, quality prevention of mother-
to-child HIV transmission (PMTCT) and pediatric (Peds) programs by 
developing adaptable training tools, utilizing operational research to 
identify and implement models of service delivery adapted to district, 
regional, sub-national and national contexts; (2) provides technical 
expertise and support to countries in planning, implementing, and 
evaluating effective strategies for scaling up of sustainable programs 
for the prevention, diagnosis, and treatment of HIV/AIDS, tuberculosis, 
and other opportunistic infections in women, infants, and children, 
including linking PMTCT/Peds HIV programs with HIV clinical and 
preventive services and other maternal and child health settings/
contexts; (3) builds national capacity for and provides guidance on 
development of policy for formulations for and access to appropriate 
long-term combination ART for HIV-infected children; (4) conducts 
operational research in collaboration with country programs to promote 
best practices, address barriers, and respond to emerging scientific 
issues for PMTCT/Peds HIV service delivery; (5) collaborates with 
international partners to contribute to the scientific body of 
knowledge on global PMTCT/Peds and broader maternal and child health 
issues and to develop and disseminate tools, guidelines, and policies 
to translate research for improved program implementation in resource-
constrained countries; (6) provides support for continuous quality 
improvement of PMTCT and Peds HIV care and treatment programs, 
including those within broader maternal and child health programs; (7) 
supports analysis of program costs and cost-effectiveness to assist 
with prioritization, inform program planning, and determine appropriate 
rates of program expansion; (8) acts as a key part of a broader CDC 
strategic response to address health needs and gender-related issues of 
maternal and child health worldwide, supporting a comprehensive, 
multidisciplinary approach to building maternal and child health 
services and systems capacity in host countries; (9) establishes 
strategic public private partnerships for HIV maternal and child health 
services and systems capacity in host countries; (10) ensures 
scientific excellence for all branch manuscripts, protocols, and 
programs in collaboration with the DGHT OD science office; and (11) 
collaborates with other DGHT branches; other CDC and HHS programs and 
offices; other USG agencies; and other national and international 
organizations.
    Epidemiology and Surveillance Branch (CWGG). (1) Builds the 
capacity of countries to develop and/or enhance HIV-related 
surveillance systems and use the results of surveillance systems and 
surveys for impact monitoring,

[[Page 76496]]

program planning, and HIV policy-making; (2) implements and evaluates 
novel approaches for conducting surveillance and surveys including 
small area estimation of HIV prevalence and key population size 
estimation; (3) provides capacity-building technical assistance for in-
country HIV-related epidemiologic investigations; (4) supports surveys 
and surveillance systems that measure HIV-related behaviors, HIV 
prevalence and incidence, uptake of HIV related services, clinical 
outcomes, and health status among the general population and at-risk 
populations; (5) develops normative guidance to improve the collection 
and analysis of HIV surveillance data including morbidity and 
mortality; (6) assists and provides technical expertise and training on 
collection, analysis, interpretation, dissemination, and use of HIV 
surveillance data; (7) assists and strengthens capacity of host country 
governments and organizations to assess and ensure the quality of the 
data collected in HIV-related surveillance systems and clinic-based HIV 
data systems; (8) coordinates, oversees, or assists in the formulation 
of HIV surveillance related funding/budgets and in the execution of a 
variety of acquisition and assistance awards; (9) ensures scientific 
excellence for relevant manuscripts, protocols, and programs in 
collaboration with the DGHT OD science office; and (10) collaborates 
with other DGHT branches, other CDC and HHS programs and offices, other 
USG agencies, and other national and international organizations as 
appropriate.
    Economics and Health Services Research Branch (CWGH). (1) 
Identifies priority information needs for program planning, resource 
allocation, efficiency and program integration, and develops economic 
analysis and operational research activities; (2) implements economic 
studies, including cost and cost-effectiveness studies, and applies 
advanced modeling techniques to inform and optimize global health 
planning, policy and programs, and provide a broader understanding of 
the effects of health programs on improving economic and other non-
health outcomes; (3) supports USG efforts in projecting financing needs 
to efficiently meet program targets in areas of prevention, care and 
treatment, and human resources for health (HRH); (4) guides development 
and implementation of monitoring systems to routinely capture program 
expenditure data to support planning, accountability and efficient 
programming; (5) trains and mentors partner country personnel in the 
methods and application of economic analysis of global health programs 
and policy; (6) provides technical input, guidance, review and 
implementation support to operational research on and evaluation of 
global HIV/AIDS activities; (7) provides technical input on the 
development of partner country health finance systems and capacity to 
develop sustainable and accountable programs, and assists in the 
implementation of national AIDS spending assessment activities; (8) 
implements and provides technical guidance on HIV/AIDS resource 
tracking exercises and monitoring of HIV/AIDS spending; (9) assesses 
financial flows and bottlenecks to financing service delivery of HIV/
AIDS interventions in order to improve efficient use and allocation of 
funds; (10) works with health and budget officials to further 
understanding of issues with a view to improving and sustaining the HIV 
program as well as improving communication between Ministries of Health 
and Finance; (11) strengthens the capacity of in-country counterparts 
of HIV financing, sustainability, and public financial management 
concepts and practices; (12) develop, models, and analyzes the HIV/AIDS 
investment and assess the direct impact and broader macroeconomic 
impacts of the HIV/AIDS investment; (13) participates in USG 
interagency technical working groups and provides technical leadership 
to address HIV/AIDS economics and finance, Health Systems Strengthening 
(HSS), and HRH issues and initiatives; (13) provides technical support 
for the routine monitoring of health-related governance including 
financial accountability, programmatic transparency, policy development 
and enforcement, and engagement and regulation of the private health 
sector, including the Global Fund to Fight AIDS, Tuberculosis, and 
Malaria; (14) develops the HSS operational research agenda for DGHT and 
implements public health evaluations related to health systems; (15) 
provides broad HSS technical assistance and support to USG in-country 
teams and host countries to improve the delivery of HIV and other 
health services and work toward transition to country ownership of 
program; (16) supports branches in strengthening health systems, 
developing metrics to assess DGHT's contribution to HSS and 
implementing monitoring systems to routinely collect DGHT's health 
system impact, especially in the areas of laboratory systems, maternal 
child health services, HIV care and treatment service delivery, blood 
safety programs, and prevention services; (17) helps define CDC's role 
and identify priority needs for strengthening HRH to support 
sustainability of HIV programs; (18) provides HRH technical assistance 
and other support to plan and meet priority HRH needs, including pre-
service and in- service training, task-shifting, capacity-building of 
accreditation and credentialing bodies, HRH planning and management, 
workplace performance and safety, quality of nursing and midwifery 
staffing in HIV service delivery, and the development of human resource 
information systems and their use in health decision-making; (19) 
conducts monitoring and evaluation of US-supported HRH activities, to 
help inform U.S. resource and program decision-making; (20) conducts 
policy analysis and generate evidence to enact evidence-based laws and 
policies for the sustainable scale-up of the HIV/AIDS response in U.S. 
supported HIV/AIDS programs; (21) supports operational research 
activities and public health evaluations that address current HRH 
questions and monitoring needs; (22) ensures scientific excellence for 
all branch manuscripts, protocols, and programs in collaboration with 
the DGHT OD science office; and (23) collaborates with other DGHT 
branches other CDC and HHS programs and offices, other USG agencies, 
and other national and international organizations.
    Overseas Strategy and Management Branch (CWGJ). (1) Provides and 
coordinates support to facilitate effective design and delivery of 
global HIV and TB activities in DGHT country programs in the areas of 
program strategy and implementation, program monitoring and evaluation, 
health diplomacy, fiscal management, procurement, personnel, extramural 
programs, and other domains; (2) serves as the official and overarching 
linkage between DGHT overseas offices and CDC, including DGHT OD and 
other DGHT Branches, components of CGH other than DGHT, and other 
relevant offices of CDC, HHS, and USG; (3) recruits, hires, and 
supervises DGHT program directors, and plays a major role in those same 
functions for DGHT Program Deputy Directors; (4) coordinates the hiring 
of all US Direct Hire (USDH) employees to DGHT overseas positions, and 
manages their pre-deployment training, preparation, and orientation to 
those critical positions; (5) facilitates and provides as needed short- 
and long-term

[[Page 76497]]

consultation, technical assistance, and backstopping for program issues 
to DGHT country offices; (6) manages the Country Office Management and 
Accountability System (CMAS), a principal DGHT process for 
accountability across a multiple core functions for performance; (7) 
provides long-term management and operations support for smaller DGHT 
overseas offices; and (8) serves as the CDC representative on 
interagency country support teams for the President's Emergency Plan 
for AIDS Relief.
    Program Budget and Extramural Management Branch (CWGK) (1) 
Coordinates all DGHT procurement and extramural activities in creating 
spend plans in compliance with federal appropriations law, 
congressional intent, and global HIV/AIDS policies; (2) facilitates and 
manages the development, clearance, and award of all new and ongoing 
DGHT headquarters and field grants, cooperative agreements, and 
contracts; (3) provides technical assistance and guidance to the 
countries and branches on budget and extramural issues including 
assisting programs in determining the appropriate funding mechanism to 
support global HIV/AIDS activities; (4) provides training and tools to 
DGHT country programs to improve budget and cooperative agreement 
management; (5) manages DGHT headquarters budget and tracks overall 
DGHT budget, which includes conducting budget planning exercises and 
managing the annual close-out process; (6) provides funding and 
budgetary data for regular reports including the Headquarters 
Operational Plan, GAO and IG audits, country Annual Program Results to 
OGC, and other requests for data; (8) reviews and provides input on 
budgetary and procurement policy-related documents; (9) liaises and 
collaborates, as appropriate, with the DGHT Associate Director for 
Science, other financial and procurement-related units and offices 
including Office of Financial Management, as well as other CDC and HHS 
offices, OGC, and other USG agencies; and (10) collaborates with other 
DGHT branches; other CDC and HHS programs and offices; other USG 
agencies; and other national and international organizations.
    Global Tuberculosis Prevention and Control Branch (CWGL). (1) 
Provides technical assistance and builds capacity in developing and 
implementing sustainable comprehensive global TB prevention and control 
programs. This includes prevention, diagnosis, and treatment services 
for TB, HIV/AIDS and other opportunistic infections; (2) coordinates 
Division and center international TB activities; (3) coordinates the 
assessment of immigration and its impact on TB patterns in the U.S. and 
assists with the evaluation of overseas TB screening procedures for 
immigrants and refugees; (4) conducts and coordinates operational 
research and demonstrations to improve both the overseas screening for 
tuberculosis of immigrants and refugees and the domestic follow-up of 
those entering with suspected TB (done in collaboration with other 
CIOs); (5) collaborates with WHO, the World Bank, IUATLD, USAID, and 
others to improve the quality of TB programs globally by supporting 
implementation of the WHO-recommended directly observed therapy, short-
course strategy; (6) collaborates with the nation of Botswana, WHO, the 
World Bank, IUATLD, USAID, and others, to conduct investigations into 
the diagnosis, management, and prevention of tuberculosis in persons 
with and without HIV infection; (7) provides technical expertise and 
support in addressing the AIDS pandemic in countries where both HIV and 
TB are reported in epidemic proportions; (8) collaborates with WHO, 
USAID, and several nations to reduce the impact of multi-drug resistant 
TB on global TB control; (9) prepares manuscripts for publication in 
scientific journals; (10) presents findings at national and 
international scientific meetings; (11) supervises Epidemic 
Intelligence Service Officers (EIS) in the conduct of their two year 
assignments; and (12) presents international and operational research 
findings to Advisory Council for the Elimination of Tuberculosis (ACET) 
and national and international scientific meetings.
    Science Integrity Branch (CWGM). (1) Serves as the principal 
advisor on standards related to scientific activities and human 
subjects protection within DGHA, supporting headquarters and country 
programs; (2) ensures scientific excellence in DGHA scientific 
documents disseminated to the public by coordinating scientific review 
of manuscripts for publication, abstracts for presentation, and study 
protocols; (3) provides coordination and support for implementation 
science (operational research) to maximize the effectiveness and 
quality of global HIV/AIDS interventions; (4) conducts regulatory and 
ethical reviews for activities involving human participants; (5) 
reviews funded activities for application of human research 
regulations; (6) provides oversight for DGHA implementation science-
related workgroups; (7) encourages internal and external scientific 
collaborations and partnerships; (8) ensures compliance with good 
clinical and laboratory practices (GCP and GCLP); and (9) provides 
training to support science quality and integrity at headquarters and 
in country programs.
    Management and Operations Branch (CWGN). (1) In coordination with 
appropriate CDC and CGH staff offices provides oversight, guidance and 
accountability for all administrative functions, domestic and 
international travel, human resources, and management of equipment, 
property and facilities; (2) develops and implements administrative 
policies, procedures and operations as appropriate for the Division; 
and prepares special reports and studies as required in the 
administrative management area; (3) provides leadership and guidance in 
all matters of daily operation, including recruitment, retention and 
management of a diverse, multi-disciplinary global workforce staff; (4) 
ensures timely and sufficient DGHT domestic staff placement through 
recruitment, hiring, and orienting of qualified staff; (5) ensures 
retention of qualified staff by providing workforce management and 
career development services for DGHT domestic staff; (6) ensures the 
full implementation and utilization of agency wide administrative 
systems and processes in support of Division management and operations.
    Strategy, Policy, and Communications Branch (CWGP). (1) Provides 
leadership and strategic direction for the Division in determining 
CDC's global HIV and tuberculosis (TB) objectives and priorities; (2) 
provides policy direction for the Division on sensitive or 
controversial issues impacting CDC's global HIV and TB policies and 
programs; (3) provides guidance to top agency officials on strategies 
necessary to communicate and maximize acceptance of the agency's 
positions on issues; (4) provides leadership and guidance on policy 
development and interpretation, budget formulation, and issues 
management; (5) communicates, through all relevant forms of media, the 
Division's program priorities, accomplishments, and value to both 
internal and external stakeholders; (6) leads and facilitates the 
Division's external relations with key non-governmental partners, 
faith-based partners, community-based partners, international partners 
and other constituencies; and (7) facilitates the Division's efforts to 
work closely with multilateral partners to continually

[[Page 76498]]

improve joint planning, data use, and strategic alignment to maximize 
impact in the fight against HIV/AIDS globally.
    Special Initiatives Branch (CWGQ). (1) Supports key leadership in 
assessing issues, identifying mitigation options, managing resolutions, 
coordinating DGHT responses to complex issues; (2) convenes relevant 
CDC SMEs to facilitate quick resolution of critical and complex 
concerns; (3) assures coordination across DGHT branches, horizontal and 
vertical, and with other relevant CDC organizations units in response 
to priority issues as needed; (4) convenes relevant CDC SMEs to 
conceive, define and develop concept notes which describe new Global 
HIV/AIDS special initiatives addressing program and/or operations 
issues; (5) communicates findings and status of current and ongoing 
priority issues resolution with DGHT Director and senior leadership on 
a timely basis; (6) initiates foundation documents (task trackers, 
scopes of work, list of working group participants, reporting 
platforms) for priority initiatives requiring cross branch 
collaboration; (7) investigates options for preventing or early 
detection of emerging issues that impact on effective/efficient use of 
resources; and (8) directs DGHT external assignees (both domestic and 
international) to assure DGHT HIV/AIDS expertise and technical 
assistance is provided to external partners effectively and efficiently 
while also assuring CDC directly learns and benefits from these 
partnerships with other organizations.
    Health Informatics, Data Management, and Statistics Branch (CWGR). 
(1) Provides leadership and technical expertise to DGHT, agency, other 
US government agency, multilateral organizations, and implementing 
partners in the development, dissemination, and implementation of 
information system, data management, analytic, and statistical 
standards, guidance, methods and solutions; (2) provides specialized 
expertise in health information systems, data management, data 
analytics and statistics across the life cycle of HIV implementation 
science, evaluation, and research projects, including expertise study 
design, sample design and sample size estimation, questionnaire 
development, information system design and development, data capture, 
management, monitoring and use, statistical analysis, report and 
manuscript writing, and data documentation, archival and dissemination; 
(3) provides specialized expertise in information systems, data 
management and statistics to DGHT-supported and other HIV surveillance 
and survey systems and activities to promote better understanding of 
HIV epidemics and HIV program outcomes and impact; (4) assures 
statistical, data management, and analytic integrity of DGHT and other 
global HIV activities and projects through technical review of 
concepts, protocols, reports, manuscripts and other products; (5) 
provides leadership and statistical expertise to agency and other US 
government agencies, multilateral organizations to promote statistical 
innovation and advance novel approaches in the analysis and modeling of 
HIV epidemics and evaluation of HIV programs; (6) collaborates with 
DGHT branches and country offices, host country governments and 
implementing partners to develop efficient and sustainable approaches 
to improve the use of national routine health information systems for 
program monitoring and improvement; (7) provides technical support to 
DGHT, agency, and interagency global HIV initiatives to strengthen 
capacity to collect, exchange, access, manage, analyze, use, and 
release HIV-related data to inform decisions to allocate resources and 
strengthen programs, including the advancement of innovative techniques 
and the appropriate use of technology; (8) collaborates with CGH in 
assuring that DGHT-sponsored information systems comply with all 
legislatively mandated requirements, including information systems 
security, capital planning, and reporting requirements; (9) builds 
global capacity for efficient and sustainable data management and 
health information system design, implementation, and use, by 
promoting, supporting and training a DGHT-led community of practice who 
identify and promote best practices and identify key competencies and 
curricula needed to advance data management and health information 
systems; (10) builds and maintains an enterprise performance monitoring 
data warehouse and engages in technical partnerships with DGHT regional 
and country offices to apply appropriate data management and analytic 
methodology to data systems for performance monitoring, accountability, 
and impact; (11) assures robust, cost effective and sustainable data 
management and information system infrastructure and methodologies for 
global HIV projects, by providing reviews of program and research data 
management plans, disseminating guidelines and policy for data 
management standards, and, where appropriate, monitoring for adherence 
to standards and guidelines; (12) advises about the resources needed to 
execute health information system, data management, analytic, and 
statistical functions, including human resources, staffing plans, and 
extramural activities; (13) supports the integration of HIV data into 
more comprehensive health information systems, the development of 
comprehensive health information systems, the development of metrics 
for monitoring and evaluating the implementation and functioning of 
health information systems; (14) provides technical assistance to DGHT 
regional and country offices and host national governments to 
strengthen health information systems, including strategic planning, 
systems needs assessments, identifying and resolving gaps, describing 
data standards and data exchange needed across systems, and developing 
standards for system interoperability; and (15) collaborates with 
agency, interagency and multilateral organizations to develop 
standards, tools, and guidance to improve the secure collection and use 
of HIV associated data, including guidance and tools to improve 
standardized definitions for HIV-related data, open source tools for 
the implementation of patient and program monitoring systems; security 
and confidentiality guidance for HIV data; and guidance on unique 
identification and matching of patient data across information systems.
    Monitoring, Evaluation, and Data Analysis Branch (CWGS). (1) 
Develops, implements and evaluates standard and novel approaches to 
program monitoring and evaluation of inputs, outputs, outcomes and 
impacts for facility- and community-based HIV/AIDS programs, 
appropriate to the level and type of US government support; (2) 
provides support and technical expertise at all stages of evaluation, 
including process and outcome, using quantitative, qualitative and 
mixed methods in global HIV/AIDS and TB programs; (3) promotes and 
supports agency and extramural program performance and accountability 
outcome measurement; (4) assists in and provides training to improve 
HIV/AIDS program monitoring and evaluation, including site-based 
service and data quality assessments, M&E systems assessment, and data 
visualization, analysis and use for program improvement; (5) provides 
support and technical expertise to US agency collaborations, in-country 
teams and multinational partners to monitor and evaluate the outputs, 
outcomes, and impact of US supported global HIV/AIDS activities; (6) 
develops, implements and supports innovative

[[Page 76499]]

analytical approaches integrating multiple sources of data and in using 
the results for impact monitoring, planning, and HIV/AIDS policy-
making; (7) supports and strengthens global and country capacity to 
monitor and evaluate HIV/AIDS prevention, care, treatment programs, 
health system strengthening, other related global health programs, and 
health systems through the development of standards, guidelines, 
curricula, and other tools; (8) coordinates, oversees, or assists in 
the formulation of M&E funding/budgets and in the execution of 
extramural awards; and (9) collaborates with other DGHT branches, other 
CDC and HHS programs and offices, other USG agencies, and other 
national and international organizations.

James Seligman,
Acting Chief Operating Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2015-30968 Filed 12-8-15; 8:45 am]
BILLING CODE 4160-18-P